Browsing Tag
adult vaccines
2 posts
GSK wins FDA approval to extend Arexvy RSV vaccine to at-risk adults aged 18 to 49, opening 21 million-strong US market
FDA expands Arexvy approval to at-risk adults 18-49, opening 21M-strong US market. Read what this means for GSK, Pfizer, Moderna, and the RSV vaccine landscape.
Dr. Reddy’s Laboratories partners with Sanofi Healthcare India for vaccine distribution
In a landmark move aimed at enhancing healthcare access across India, Dr. Reddy’s Laboratories Ltd. has announced an…